Back to Search
LAUREN HUNSICKER, PHARMD.
PHARMD.
Pharmacist
NPI: 1912326505Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
RP445697(PA)
Research & Publications (20)
Impact of irbesartan, blood pressure control, and proteinuria on renal outcomes in the Irbesartan Diabetic Nephropathy Trial.
PMID 15485429·Kidney Int Suppl·2004
6-review
Activities and relative affinities of divalent metals in unmodified and phosphorothioate-substituted hammerhead ribozymes.
PMID 11001099·J Inorg Biochem·2000
8-other
Baseline characteristics of participants in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial.
PMID 19022547·Am J Kidney Dis·2009
4-observational
Use of cardioprotective medications in kidney transplant recipients.
PMID 19519808·Am J Transplant·2009
4-observational
OPTN policy regarding prioritization of patients with hepatopulmonary syndrome: does it provide equitable organ allocation?
PMID 18416736·Am J Transplant·2008
8-other
Physician access and early nephrology care in elderly patients with end-stage renal disease.
PMID 18509317·Kidney Int·2008
8-other
Effects of sulodexide in patients with type 2 diabetes and persistent albuminuria.
PMID 18089623·Nephrol Dial Transplant·2008
4-observational
Short- and long-term outcomes with the use of kidneys and livers donated after cardiac death.
PMID 17061982·Am J Transplant·2007
4-observational
A report of the Lisbon Conference on the care of the kidney transplant recipient.
PMID 17452912·Transplantation·2007
8-other
Rationale and design of the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trial.
PMID 16923411·Am Heart J·2006
4-observational
The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.
PMID 16997053·Am J Kidney Dis·2006
8-other
Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective.
PMID 16612330·Kidney Int·2006
8-other
Effect of dialysis center profit-status on patient survival: a comparison of risk-adjustment and instrumental variable approaches.
PMID 17116120·Health Serv Res·2006
4-observational
Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations.
PMID 16120823·J Am Soc Nephrol·2005
2-rct
Total plasma homocysteine and arteriosclerotic outcomes in type 2 diabetes with nephropathy.
PMID 16162814·J Am Soc Nephrol·2005
4-observational
Design of the Dialysis Access Consortium (DAC) Aggrenox Prevention Of Access Stenosis Trial.
PMID 16317809·Clin Trials·2005
8-other
Design of the Dialysis Access Consortium (DAC) Clopidogrel Prevention of Early AV Fistula Thrombosis Trial.
PMID 16317810·Clin Trials·2005
8-other
The incidence of tuberous breast deformity in asymmetric and symmetric mammaplasty patients.
PMID 16327600·Plast Reconstr Surg·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 912 AIRPORT CENTER DR
ALLENTOWN, PA 18109 - Phone
- (610) 573-5711
Quick Facts
- NPI
- 1912326505
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile